Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
出版年份 2021 全文链接
标题
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-25
DOI
10.3389/fimmu.2021.621956
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of rs610604 in TNFAIP3 and rs17728338 in TNIP1 gene polymorphisms with psoriasis susceptibility: a meta-analysis of case-control studies
- (2020) Hai-bo Gong et al. BMC Medical Genetics
- Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice
- (2020) Momoko Nakao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The current landscape of psoriasis genetics in 2020
- (2020) Kotaro Ogawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Baseline characteristics of patients with moderate‐to‐severe psoriasis according to previous systemic treatment exposure: the PROSE study population
- (2020) M. Augustin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A phase I, randomized, double‐blind study to assess the safety, tolerability, and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis
- (2020) G. Berstein et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations
- (2019) Chihiro Imura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
- (2019) Stefan Schreiber et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of mirikizumab ( LY 3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study
- (2019) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks
- (2019) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- The IL-23/IL-17 pathway in human chronic inflammatory diseases – new insight from genetics and targeted therapies
- (2019) Elisabetta Bianchi et al. MICROBES AND INFECTION
- Differential Roles of the mTOR-STAT3 Signaling in Dermal γδ T Cell Effector Function in Skin Inflammation
- (2019) Yihua Cai et al. Cell Reports
- The biology and functional importance of MAIT cells
- (2019) Dale I. Godfrey et al. NATURE IMMUNOLOGY
- Molecular mechanisms of lineage decisions in metabolite-specific T cells
- (2019) François Legoux et al. NATURE IMMUNOLOGY
- STAT 3 but not STAT 4 is critical for γδT17 cell responses and skin inflammation
- (2019) Rasmus Agerholm et al. EMBO REPORTS
- The CCL20 and CCR6 axis in psoriasis
- (2019) Kazuhisa Furue et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- MAIT cells are imprinted by the microbiota in early life and promote tissue repair
- (2019) Michael G. Constantinides et al. SCIENCE
- IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection
- (2019) Huimeng Wang et al. Science Immunology
- Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
- (2019) Amanda Kvist-Hansen et al. Dermatology and Therapy
- Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
- (2018) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prevalence and incidence of psoriatic arthritis: A systematic review and meta-analysis
- (2018) Lorenza Scotti et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
- (2018) Michael P. Schön et al. Frontiers in Immunology
- Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
- (2018) Jason E. Hawkes et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- (2018) Kenneth B Gordon et al. LANCET
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis
- (2018) Martina Morelli et al. Journal of Immunology Research
- The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study
- (2017) JianZhong Zhang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Psoriasis and comorbid diseases
- (2017) Junko Takeshita et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
- (2017) Kristian Reich et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma
- (2016) Maria Liljevald et al. AUTOIMMUNITY REVIEWS
- mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production
- (2016) Feidi Chen et al. JOURNAL OF IMMUNOLOGY
- A systematic review of worldwide epidemiology of psoriasis
- (2016) I.M. Michalek et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
- (2016) David R Withers et al. NATURE MEDICINE
- Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
- (2015) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
- (2015) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
- (2015) Joseph R. Maxwell et al. IMMUNITY
- Identification of Two Loci Associated with Generalized Pustular Psoriasis
- (2015) Zheng Zhang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- Runx3 specifies lineage commitment of innate lymphoid cells
- (2015) Takashi Ebihara et al. NATURE IMMUNOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis
- (2015) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
- (2015) S. Okada et al. SCIENCE
- IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
- (2014) G. L. Stritesky et al. JOURNAL OF IMMUNOLOGY
- Identification of CD25+ T Cells As Fetal Thymus-Derived Naturally Occurring IL-17 Producers
- (2014) K. Shibata et al. JOURNAL OF IMMUNOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The IL-17A-Producing CD8 + T-Cell Population in Psoriatic Lesional Skin Comprises Mucosa-Associated Invariant T Cells and Conventional T Cells
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
- (2014) Charles W. Lynde et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Heritability of psoriasis in a large twin sample
- (2013) A.S. Lønnberg et al. BRITISH JOURNAL OF DERMATOLOGY
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses
- (2013) Andreas Schlitzer et al. IMMUNITY
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- In Vivo Induction of Cutaneous Inflammation Results in the Accumulation of Extracellular Trap-Forming Neutrophils Expressing RORγt and IL-17
- (2013) Romy R.M.C Keijsers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Pattern Recognition Receptor NOD2 Mediates Staphylococcus aureus –Induced IL-17C Expression in Keratinocytes
- (2013) Sarah A. Roth et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A large-scale screen for coding variants predisposing to psoriasis
- (2013) Huayang Tang et al. NATURE GENETICS
- Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation
- (2013) Bryan Vander Lugt et al. NATURE IMMUNOLOGY
- Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens
- (2013) Ansuman T Satpathy et al. NATURE IMMUNOLOGY
- PSORS2 Is Due to Mutations in CARD14
- (2012) Catherine T. Jordan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
- (2012) Rosa Parisi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
- (2012) Lam C Tsoi et al. NATURE GENETICS
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo
- (2011) Jonas Mudter et al. INFLAMMATORY BOWEL DISEASES
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
- (2011) Vladimir Ramirez-Carrozzi et al. NATURE IMMUNOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
- (2010) M. Dusseaux et al. BLOOD
- Primary human keratinocytes efficiently induce IL-1-dependent IL-17 in CCR6+ T cells
- (2010) Philipp Muhr et al. EXPERIMENTAL DERMATOLOGY
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2
- (2010) Eva Ellinghaus et al. NATURE GENETICS
- Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
- (2010) Ulrike Hüffmeier et al. NATURE GENETICS
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells
- (2009) Jan D. Haas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets
- (2009) Julie C Ribot et al. NATURE IMMUNOLOGY
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Functional Characterization of IL-17F as a Selective Neutrophil Attractant in Psoriasis
- (2008) Hideaki Watanabe et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search